1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. NEULAND LABORATORIES LTD.

Neuland Laboratories Ltd. NSE: NEULANDLAB | BSE: 524558

Neuland Laboratories Ltd. Live Share Price Today, Share Analysis and Chart

Expensive Performer
about

Neuland Laboratories is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets.

Read More

12096.00 36.00 (0.30%)

33.17% Fall from 52W High

18,648 NSE+BSE Volume

NSE 07 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
US FDA Observation
Neuland Labs gets Form 483 with one observation from the US FDA for its Sangareddy facility See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
75.0 / 100
Valuation Score
Expensive Valuation
13.5 / 100
Momentum Score
Technically Neutral
43.5 / 100
Expensive Performer These stocks are strong in quality but with mid-range technical aspects. Their strong financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
17,600
1Yr Price target upside is 46%
2 analysts

23

S

6

W

7

O

1

T

SWOT Analysis

Neuland Laboratories Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

14 Feb, 2025 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
11 Feb, 2025 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
pdf link
11 Feb, 2025 TRENDLYNE
Neuland Laboratories Results Earnings Call for Q3FY25
Neuland Laboratories Results Earnings Call for Q3FY25
video link
12 Nov, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
06 Nov, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
pdf link
06 Aug, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
01 Aug, 2024 TRENDLYNE
Neuland Laboratories Results Earnings Call for Q1FY25
Neuland Laboratories Results Earnings Call for Q1FY25
audio video link
01 Aug, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
pdf link
17 May, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
14 May, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-An…
pdf link
14 May, 2024 TRENDLYNE
Neuland Laboratories Results Earnings Call for Q4FY24
Neuland Laboratories Results Earnings Call for Q4FY24
audio video link
13 Feb, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Ea…
pdf link AI Summary
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
07 May, 2025 INDIA RATINGS
India Ratings Assigns Neuland Laboratoriess Additional Bank Facilities IND A+/P…
link
10 Mar, 2025 INDIA RATINGS
India Ratings Revises Outlook on Neuland Laboratoriess Bank Facilities to Posit…
link
27 Mar, 2024 CRISIL RATINGS
Neuland Laboratories Limited
Neuland Laboratories Limited:Long-term rating upgraded to 'CRISIL A+/Stable'; short-term rating reaffirmed
link
08 Feb, 2024 INDIA RATINGS
India Ratings Upgrades Neuland Laboratories Bank Facilities to IND A+; Outlook …
link
20 Oct, 2023 INDIA RATINGS
India Ratings Discontinues Voluntary Issuer Rating Disclosure due to Regulatory…
link
25 Apr, 2023 CRISIL RATINGS
Neuland Laboratories Limited
Neuland Laboratories Limited:Ratings upgraded to 'CRISIL A/Stable/CRISIL A1'
link
16 Nov, 2022 INDIA RATINGS
India Ratings Upgrades Neuland Laboratories to IND A; Outlook Stable
link
21 Apr, 2022 CRISIL RATINGS
Neuland Laboratories Limited
Neuland Laboratories Limited:Rated amount enhanced
link
09 Sep, 2021 CRISIL RATINGS
Neuland Laboratories Limited
Neuland Laboratories Limited:Update on Neuland Laboratories Limited
link
18 Aug, 2021 INDIA RATINGS
India Ratings Affirms Neuland Labs at IND A-/ Stable
link
14 Apr, 2021 CRISIL RATINGS
Neuland Laboratories Limited
Neuland Laboratories Limited:'CRISIL A-/Stable/CRISIL A2+' assigned to Bank Debt
link
09 Nov, 2020 INDIA RATINGS
India Ratings Assigns Neuland Laboratories Additional Term Loan IND A-/Stable; …
link
All Credit Ratings
10 Feb, 2025 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
06 Nov, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
01 Aug, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
12 May, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
10 May, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
08 Feb, 2024 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
07 Nov, 2023 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
03 Aug, 2023 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
11 May, 2023 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-In…
pdf link
13 Feb, 2023 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarte…
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarte…
pdf link
13 Feb, 2023 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Outcome for Unaudited Financ…
NEULAND LABORATORIES LTD. - 524558 - Board Meeting Outcome for Unaudited Financ…
pdf link
10 Nov, 2022 BSE INDIA
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarte…
NEULAND LABORATORIES LTD. - 524558 - Unaudited Financial Results For The Quarte…
pdf link

Neuland Laboratories Ltd. FAQ

How is Neuland Laboratories Ltd. today?
Neuland Laboratories Ltd. today is trading in the green, and is up by 0.30% at 12096.00.
Neuland Laboratories Ltd. is currently trading up 0.30% on an intraday basis. In the past week the stock rose 0.87%. stock has been down -15.10% in the past quarter and rose 64.40% in the past year. You can view this in the overview section.